GSG Advisors LLC Has $450,000 Holdings in UnitedHealth Group Incorporated $UNH

GSG Advisors LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 13.7% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 778 shares of the healthcare conglomerate’s stock after acquiring an additional 94 shares during the period. GSG Advisors LLC’s holdings in UnitedHealth Group were worth $450,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Citizens National Bank Trust Department boosted its holdings in shares of UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after acquiring an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH increased its position in UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after buying an additional 1,465 shares during the period. Sherbrooke Park Advisers LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at about $515,000. Full Sail Capital LLC boosted its holdings in UnitedHealth Group by 2.1% in the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after purchasing an additional 33 shares during the period. Finally, Soros Fund Management LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $39,413,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares of the company’s stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 12.0%

UnitedHealth Group stock opened at $304.02 on Monday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a 50 day moving average price of $288.91 and a two-hundred day moving average price of $395.81. The firm has a market cap of $275.34 billion, a price-to-earnings ratio of 13.17, a PEG ratio of 1.96 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period last year, the business posted $6.80 earnings per share. The business’s revenue was up 12.9% on a year-over-year basis. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

Analysts Set New Price Targets

Several equities analysts have weighed in on UNH shares. Barclays reaffirmed an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Mizuho reduced their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. Oppenheimer cut their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Finally, Wolfe Research decreased their price target on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 20th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Hold” and a consensus price target of $366.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.